Medical Marijuana 411 values providing our readers with information about the latest cannabis related topics for educational purposes and not for the intention of advocacy. This is not an advocacy-based organization. For ailment specific questions, please consult your primary care physician.
16 Mar

Torture Advocate Bybee Rules Against Epis

By Fred Gardner  |  Published in O’Shaughnessy’s A three-judge panel from the Ninth Circuit Court of Appeals has upheld a 10-year mandatory minimum sentence for Bryan Epis, 42, the first California medical marijuana grower convicted in federal court in the Prop 21 era, Jay Bybee was one of those three judges. The jugdes’ 11-page decision

Continue Reading

04 May

Medical Marijuana Saves Life of Child, but Doctors Reluctant to Make Life Better for Many Others

Two-year old Cash Hyde was weened off of 125mg of various prescriptions after father turned to marijuana oil to save the life of his son after brain cancer had taken over the toddler. All too often, parents worry about their children about the wrong dangers and for Cash’s father, he had had enough. Seeing very

Continue Reading

06 Apr

Project CBD Catches Cancer.gov Scrubbing Site

By CBDiary |  Published in ProjectCBD.org Remember when we reported on the 24th that the National Cancer Institute, U.S. National Institutes of Health, had finally recognized the antitumor properties of Cannabis?: “The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. In the practice

Continue Reading

27 Oct

Project CBD: Marijuana Specialists Plan To Study New Strains

Fifteen members of the Society of Cannabis Clinicians -the doctors’ group founded by Tod Mikuriya in 1999 and now led by Jeffrey Hergenrather- met in Oakland Dec. 11 (2009.) UCSF professor Donald Abrams recounted the obstacles he faced in conducting clinical trials with government-issued cannabis and getting his results published in peer-reviewed medical journals. The ensuing discussion focused on how SCC doctors might go about evaluating the effectiveness of high-CBD strains as they become available to patients in the year ahead.

Continue Reading